Statements (15)
Predicate | Object |
---|---|
gptkbp:instanceOf |
antiviral drug
|
gptkbp:approvedBy |
gptkb:Japan
|
gptkbp:ATCCode |
J05AH04
|
gptkbp:CASNumber |
203120-17-6
|
gptkbp:chemicalFormula |
C15H24N4O7
|
gptkbp:developedBy |
gptkb:Daiichi_Sankyo
|
gptkbp:drugClass |
neuraminidase inhibitor
|
https://www.w3.org/2000/01/rdf-schema#label |
laninamivir
|
gptkbp:legalStatus |
prescription only
|
gptkbp:marketedAs |
Inavir
|
gptkbp:mechanismOfAction |
inhibits influenza virus neuraminidase
|
gptkbp:routeOfAdministration |
inhalation
|
gptkbp:usedFor |
influenza
|
gptkbp:bfsParent |
gptkb:Neuraminidase_(NA)
|
gptkbp:bfsLayer |
7
|